Journal profile · Chemistry, Analytical
Journal of biomolecular screening
ISSN 1087-0571 · SAGE Publications Inc. · UNITED STATES · Quarterly · Founded 1996
Journal of biomolecular screening: subscription journal; review 4–8 weeks (community reports); community-reported acceptance: easy; 0 articles in 2025.
Scope
Aims, scope and focus
Journal of biomolecular screening is published by SAGE Publications Inc.. By OpenAlex counts of its recent articles, its largest topics are Advanced Biosensing Techniques and Applications, Computational Drug Discovery Methods and Receptor Mechanisms and Signaling, together about 41.6% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
SLAS Discovery is no longer being published by Sage. This site hosts content published between 1996 and December 2021. Please submit your manuscripts to the new submission platform at: https://www.journals.elsevier.com/slas-discovery View full journal description
From the journal's Aims & Scope
Research area (LetPub): Chemistry, Analytical
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Biosensing Techniques and ApplicationsBiochemistry, Genetics and Molecular Biology16.8%
- Computational Drug Discovery MethodsComputer Science14.6%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology10.3%
- Advanced Fluorescence Microscopy TechniquesBiochemistry, Genetics and Molecular Biology7%
- Protein Kinase Regulation and GTPase SignalingBiochemistry, Genetics and Molecular Biology5.4%
- Cell Image Analysis TechniquesBiochemistry, Genetics and Molecular Biology4.9%
- bioluminescence and chemiluminescence researchBiochemistry, Genetics and Molecular Biology4.3%
- Neuroscience and Neuropharmacology ResearchNeuroscience3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Analytical Chemistry | Q2 | 42/110 | 62nd |
| Drug Discovery | Q2 | 55/146 | 62nd |
| Biotechnology | Q2 | 91/257 | 64th |
| Molecular Medicine | Q2 | 91/165 | 45th |
| Pharmacology | Q2 | 119/300 | 60th |
| Biochemistry | Q2 | 198/407 | 51st |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.41LetPub ·
- SJR 2026-06
- 0.99LetPub ·
- SNIP 2026-06
- 0.69LetPub ·
- h-index
- 69LetPub ·
- h-index
- 10OpenAlex ·
- i10-index
- 10OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 155 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 8 |
| 2025 | 0 | 0 | 4 |
| 2024 | 0 | 0 | 15 |
| 2023 | 0 | 0 | 6 |
| 2022 | 0 | 0 | 5 |
| 2021 | 0 | 0 | 5 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- SAGE Publications Inc.
- Country or region
- UNITED STATES
- Frequency
- Quarterly
- Founded
- 1996
- ISSN
- 1087-0571
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of biomolecular screening
How long does peer review take at Journal of biomolecular screening?
Authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Is Journal of biomolecular screening open access, and what is the APC?
Journal of biomolecular screening is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .